1419 — Human Health Holdings Income Statement
0.000.00%
- HK$299.85m
- -HK$47.83m
- HK$590.82m
- 99
- 92
- 11
- 79
Annual income statement for Human Health Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 454 | 655 | 1,122 | 1,002 | 591 |
Cost of Revenue | |||||
Gross Profit | 190 | 377 | 660 | 593 | 271 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 487 | 484 | 672 | 753 | 555 |
Operating Profit | -33.2 | 171 | 450 | 249 | 36.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -39 | 169 | 445 | 239 | 26.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -40.4 | 144 | 375 | 181 | 24.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -40.4 | 144 | 375 | 181 | 24.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -40.4 | 144 | 375 | 181 | 24.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.112 | 0.338 | 1 | 0.598 | 0.097 |
Dividends per Share |